WANG GUOQIANG,OR YAT SUN,SHEN RUICHAO,XING XUECHAO,LONG JIANG,DAI PENG,GRANGER BRETT,HE JING
申请号：
IN201727038431
公开号：
IN201727038431A
申请日:
2017.10.30
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The present invention provides compounds represented by Formula I or pharmaceutically acceptable salts stereoisomers solvates hydrates or combination thereof (I). The invention also provides pharmaceutical compositions comprising these compounds and methods of using this compounds for treating FXR mediated or TGR5 mediated diseases or conditions.
